Market Momentum: Surgery Partners Inc (SGRY) Registers a -7.35 Decrease, Closing at 22.95

Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Surgery Partners Inc (NASDAQ: SGRY) closed the day trading at $22.95 down -7.35% from the previous closing price of $24.77. In other words, the price has decreased by -$7.35 from its previous closing price. On the day, 1.22 million shares were traded. SGRY stock price reached its highest trading level at $25.15 during the session, while it also had its lowest trading level at $22.93.

Ratios:

For a better understanding of SGRY, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 12.19 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 16.54. For the most recent quarter (mrq), Quick Ratio is recorded 1.66 and its Current Ratio is at 1.80. In the meantime, Its Debt-to-Equity ratio is 1.86 whereas as Long-Term Debt/Eq ratio is at 1.78.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, UBS on October 14, 2024, initiated with a Buy rating and assigned the stock a target price of $38.

On June 28, 2024, Macquarie started tracking the stock assigning a Outperform rating and target price of $31.Macquarie initiated its Outperform rating on June 28, 2024, with a $31 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 05 ’24 when Bradley Owens bought 9,241 shares for $30.69 per share.

Bane Harrison R. sold 6,325 shares of SGRY for $196,742 on Sep 04 ’24. The National Group President now owns 48,236 shares after completing the transaction at $31.11 per share. On Sep 04 ’24, another insider, Harrison Bane, who serves as the Officer of the company, bought 6,325 shares for $31.11 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SGRY now has a Market Capitalization of 2917266432 and an Enterprise Value of 7835082240. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.91 while its Price-to-Book (P/B) ratio in mrq is 1.54. Its current Enterprise Value per Revenue stands at 2.625 whereas that against EBITDA is 13.148.

Stock Price History:

Over the past 52 weeks, SGRY has reached a high of $36.92, while it has fallen to a 52-week low of $22.25. The 50-Day Moving Average of the stock is -25.04%, while the 200-Day Moving Average is calculated to be -20.03%.

Shares Statistics:

Over the past 3-months, SGRY traded about 872.00K shares per day on average, while over the past 10 days, SGRY traded about 1414530 shares per day. A total of 126.59M shares are outstanding, with a floating share count of 71.05M. Insiders hold about 44.10% of the company’s shares, while institutions hold 68.00% stake in the company. Shares short for SGRY as of 1730332800 were 10160025 with a Short Ratio of 11.65, compared to 1727654400 on 10100790. Therefore, it implies a Short% of Shares Outstanding of 10160025 and a Short% of Float of 17.59.

Most Popular